Health-System Specialty Pharmacy Built to Evolve
Growing demand for specialty care, shifting prescriber habits, and new reimbursement models have forced stakeholders to adjust practices to optimize patient outcomes.
Growing demand for specialty care, shifting prescriber habits, and new reimbursement models have forced stakeholders to adjust practices to optimize patient outcomes.
On September 15th, we hosted a panel discussion on The Evolution of Health System Specialty Pharmacy. An esteemed panel of specialty pharmacists helped us understand why a more mature specialty…
Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…
DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…
The company will pay $970 million to increase its ownership of the Stoughton-based specialty pharmacy company to 71 percent
At Shields Health Solutions, improving lives and elevating performance are at the heart of everything we do, which is why we must show our support and drive better outcomes for…
The COVID-19 pandemic has elevated the urgency of addressing health equity and the role of social determinants of health (SDoH) in health disparities. The dynamism and growth of the specialty…
Specialty pharmacy is growing, as is Shields Health Solutions and the increasing number of partners and patients we serve around the country. In this blog, we take a look at…
Dermatology is the branch of medicine concerned with the diagnosis and treatment of skin disorders. Talk to your dermatologist, a medical doctor specializing in treating the skin, hair, and nails…
This blog was authored by the following members of our trade relations team: Kerry Mello-Parker, Director of Clinical Compliance, MJ Kelly, Medical Billing Specialist, Ben May, Director of Drug Trend…